Minerva Surgical

Minerva Surgical Interest Coverage

The Interest Coverage Ratio of Minerva Surgical (UTRS) as of Nov 3, 2026 is -9.87. In the previous year, Interest Coverage Ratio was -1.11 — a change of 790.49% (lower).

Interest Coverage

-9.87

YoY

790.49%

Last updated:

Interest Coverage Ratio of Minerva Surgical is 2022 -9.87 . Interest Coverage Ratio of Minerva Surgical was 2021 -1.11 . It decreases by 790.49% lower compared to the previous year.

The Minerva Surgical Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2019
-0.81 USD
Jan 1, 2020
-4.14 USD
Jan 1, 2021
-1.11 USD
Jan 1, 2022
-9.87 USD
The Minerva Surgical Interest Coverage history
YEARInterest CoverageYoY
-9.87+790.49%
-1.11-73.20%
-4.14+411.95%
-0.81—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Minerva Surgical Stock analysis

What does Minerva Surgical do? Minerva Surgical, Inc. generates revenue through the commercialization of minimally invasive uterine healthcare solutions designed to treat abnormal uterine bleeding without necessitating hysterectomies. The company offers a suite of products targeting structural and non-structural causes of AUB, which are utilized by OB/GYNs in hospitals, ambulatory surgical centers, and physician offices. These devices address drawbacks of alternative treatments while preserving the uterus, appealing to healthcare providers seeking effective, non-invasive options for women's health. The firm's product line includes commercially available devices for minimally invasive alternatives to hysterectomy, specifically targeting the most common causes of AUB across various uterine anatomies. OB/GYNs across multiple medical settings purchase these solutions, leveraging their ability to address treatment limitations while avoiding unnecessary surgical interventions. The company's focus on preserving the uterus through non-hysterectomy methods differentiates its offerings in the women's health technology market. Minerva Surgical's revenue model relies on sales of its medical devices to healthcare providers, particularly OB/GYNs, who integrate the products into their treatment protocols for patients with abnormal uterine bleeding. The company's solutions are positioned as alternatives to traditional hysterectomy procedures, targeting a significant unmet need in women's healthcare. This approach allows the firm to capture market share by addressing both clinical and patient preference demands for less invasive care options. Minerva Surgical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Minerva Surgical stock

Interest Coverage Ratio of Minerva Surgical is -9.87 in 2022.

Interest Coverage Ratio of Minerva Surgical changed from -1.11 to -9.87, representing a 790.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Minerva Surgical since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Minerva Surgical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Minerva Surgical

All Key Metrics — Minerva Surgical